Mixed Tumor, Mesodermal: Clinical Trials

1 trial for Mixed Tumor, Mesodermal, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Mixed Tumor, Mesodermal: new trials by email Literature Review of Mixed Tumor, Mesodermal trials Research Report on Mixed Tumor, Mesodermal

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian Cancer
Paclitaxel, Carboplatin - Ovarian Cancer, Primary Peritoneal Carcinoma
Phase 2TerminatedDana-Farber Cancer Institute122006-04-012018-09-10

Narrower conditions

Fallopian Tube Neoplasms (1)  ·  Ovarian Neoplasms (1)

Broader conditions

Adnexal Diseases (1)  ·  Endocrine Gland Neoplasms (1)  ·  Endocrine System Diseases (1)  ·  Fallopian Tube Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Female (1)  ·  Genital Neoplasms, Female (1)  ·  Gonadal Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms by Site (1)  ·  Neoplasms, Complex and Mixed (1)  ·  Neoplasms, Connective and Soft Tissue (1)

Interventions

Carboplatin (1)  ·  Paclitaxel (1)

Sponsors

Dana-Farber Cancer Institute (1)

Countries

United States (1)

Top investigators

Ursula Matulonis, MD (1)

Results publications

PMID 19058838